AAAAAA
Results: 1-25/53
IMMUNOLYMPHOSCINTIGRAPHY IN BREAST-CANCER - EVALUATION USING I-131-LABELED MONOCLONAL-ANTIBODY B72.3
Authors:
FIG LM
BROWN RS
VONMOLL L
APPELMAN HD
STEVENS R
HARNESS J
AUGUST D
SONDAK VK
CHANG AE
ZASADNY KR
FISHER SJ
JOHNSON JW
WICHA MS
COLCHER D
LICHTER AS
WAHL RL
Citation: Lm. Fig et al., IMMUNOLYMPHOSCINTIGRAPHY IN BREAST-CANCER - EVALUATION USING I-131-LABELED MONOCLONAL-ANTIBODY B72.3, Nuclear medicine and biology, 25(3), 1998, pp. 251-260
Authors:
SUGAWARA Y
FISHER SJ
ZASADNY KR
KISON PV
BAKER LH
WAHL RL
Citation: Y. Sugawara et al., PRECLINICAL AND CLINICAL-STUDIES OF BONE-MARROW UPTAKE OF FLUORINE-18-FLUORODEOXYGLUCOSE WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR DURING CHEMOTHERAPY, Journal of clinical oncology, 16(1), 1998, pp. 173-180
Authors:
SUGAWARA Y
BRAUN DK
KISON PV
RUSSO JE
ZASADNY KR
WAHL RL
Citation: Y. Sugawara et al., RAPID DETECTION OF HUMAN INFECTIONS WITH F-18 FLUORODEOXYGLUCOSE AND POSITRON-EMISSION-TOMOGRAPHY - PRELIMINARY-RESULTS, European journal of nuclear medicine, 25(9), 1998, pp. 1238-1243
Authors:
WAHL RL
KROLL S
ZASADNY KR
Citation: Rl. Wahl et al., PATIENT-SPECIFIC WHOLE-BODY DOSIMETRY - PRINCIPLES AND A SIMPLIFIED METHOD FOR CLINICAL IMPLEMENTATION, The Journal of nuclear medicine, 39(8), 1998, pp. 14-20
Authors:
WAHL RL
ZASADNY KR
MACFARLANE D
FRANCIS IR
ROSS CW
ESTES J
FISHER S
REGAN D
KROLL S
KAMINSKI MS
Citation: Rl. Wahl et al., I-131 ANTI-B1 ANTIBODY FOR B-CELL LYMPHOMA - AN UPDATE ON THE MICHIGAN PHASE-I EXPERIENCE, The Journal of nuclear medicine, 39(8), 1998, pp. 21-27
Authors:
TORIZUKA T
ZASADNY KR
WAHL RL
Citation: T. Torizuka et al., EFFECT OF DIABETES ON FDG UPTAKE IN UNTREATED PRIMARY LUNG-CANCER, The Journal of nuclear medicine, 39(5), 1998, pp. 162-162
Authors:
KORAL KF
DEWARAJA Y
LI J
LIN S
REGAN D
ZASADNY KR
FRANCIS I
KAMINSKI MS
WAHL RL
Citation: Kf. Koral et al., PRELIMINARY-REPORT OF TUMOR DOSIMETRY FROM I-131 SPECT OF PREVIOUSLY-UNTREATED PATIENTS WITH B-CELL LYMPHOMA, The Journal of nuclear medicine, 39(5), 1998, pp. 437-437
Authors:
TORIZUKA T
ZASADNY KR
KISON PV
ROMMELFANGER SG
KAMINSKI MS
WAHL RL
Citation: T. Torizuka et al., RESPONSE OF NON-HODGKINS-LYMPHOMA TO NONMYELOABLATIVE 1-13-I-ANTI-B1 RADIOIMMUNOTHERAPY - EVALUATION WITH FDG PET, The Journal of nuclear medicine, 39(5), 1998, pp. 579-579
Authors:
ROMMELFANGER SG
ZASADNY KR
GATES VL
FISHER SJ
KAMINSKI MS
WAHL RL
Citation: Sg. Rommelfanger et al., DOSIMETRY OF I-131 ANTI-B1 (ANTI-CD20) ANTIBODY FOR NON-HODGKINS-LYMPHOMA - COMPARISON OF UP-FRONT TREATMENT VS. CHEMOTHERAPY-REFRACTORY PATIENTS, The Journal of nuclear medicine, 39(5), 1998, pp. 840-840
Authors:
ZASADNY KR
KISON PV
WAHL RL
Citation: Kr. Zasadny et al., PRACTICAL TUMOR-ACTIVITY QUANTIFICATION STRATEGIES IN 2D AND 3D PET, The Journal of nuclear medicine, 39(5), 1998, pp. 1136-1136
Authors:
KORAL KF
ZASADNY KR
ACKERMANN RJ
FICARO EP
Citation: Kf. Koral et al., DEADTIME CORRECTION FOR 2 MULTIHEAD ANGER CAMERAS IN I-131 DUAL-ENERGY-WINDOW-ACQUISITION MODE, Medical physics, 25(1), 1998, pp. 85-91
Authors:
ZASADNY KR
GATES VL
KAMINSKI MS
WAHL RL
Citation: Kr. Zasadny et al., RADIOIMMUNOTHERAPY WITH I-131 ANTI-B1 (ANTI CD20) ANTIBODY DECREASES SPLEEN SIZE IN PATIENTS WITH NON-HODGKINS-LYMPHOMA, Radiology, 209P, 1998, pp. 1007-1007
Authors:
WAHL RL
ZASADNY KR
MACFARLANE DJ
KROLL S
TIDMARSH G
KAMINSKI MS
Citation: Rl. Wahl et al., COMPARISON OF PERIPHERAL HEMATOPOIETIC EFFECTS OF 75CGY TOTAL-BODY DOSE RADIOIMMUNOTHERAPY IN UNTREATED VERSES PREVIOUS-TREATED PATIENTS NON-HODGKINS-LYMPHOMA, Radiology, 209P, 1998, pp. 1008-1008
Authors:
TORIZUKA T
ZASADNY KR
RECKER B
WAHL RL
Citation: T. Torizuka et al., UNTREATED PRIMARY LUNG AND BREAST CANCERS - CORRELATION BETWEEN F-18 FDG KINETIC RATE CONSTANTS AND FINDINGS OF IN-VITRO STUDIES, Radiology, 207(3), 1998, pp. 767-774
Authors:
WAHL RL
ZASADNY KR
Citation: Rl. Wahl et Kr. Zasadny, PROPOSED PARAMETRIC IMAGES OF CANCER - QUOTIENT IMAGES OF FDG-UPTAKE PER REGIONAL BLOOD-FLOW BY O-15-WATER MAY BE AN INDICATOR OF AREAS OF TUMOR HYPOXIA, The Journal of nuclear medicine, 38(5), 1997, pp. 247-247
Authors:
TORIZUKA T
ZASADNY KR
KISON P
RUSSO JE
WAHL RL
Citation: T. Torizuka et al., KINETIC RATE CONSTANTS OF FDG PET IN PATIENTS WITH NON-HODGKIN-LYMPHOMA, The Journal of nuclear medicine, 38(5), 1997, pp. 631-631
Authors:
ZASADNY KR
GATES VL
FRANCIS I
FISHER S
KAMINSKI MS
WAHL RL
Citation: Kr. Zasadny et al., NORMAL ORGAN AND TUMOR DOSIMETRY OF I-131 ANTI-B1 (ANTI-CD20) RADIOIMMUNOTHERAPY AT NON-MARROW ABLATIVE DOSES, The Journal of nuclear medicine, 38(5), 1997, pp. 977-977
Authors:
ZASADNY KR
KISON PV
NEUHOFF A
WAHL RL
Citation: Kr. Zasadny et al., COMPARISON OF THE INFLUX-CONSTANT FOR FDG AS DETERMINED FROM 30-MINUTE AND 60-MINUTE DYNAMIC PET SCANS IN PATIENTS WITH LUNG-CANCER, The Journal of nuclear medicine, 38(5), 1997, pp. 1034-1034
Authors:
TORIZUKA T
ZASADNY KR
WAHL RL
Citation: T. Torizuka et al., COMPARISON OF FDG KINETIC RATE CONSTANTS IN PATIENTS WITH UNTREATED LUNG-CANCER AND UNTREATED BREAST-CANCER, The Journal of nuclear medicine, 38(5), 1997, pp. 1035-1035
Authors:
GATES VL
ZASADNY KR
FISHER SJ
SPAULDING S
KAMINSKI MS
WAHL RL
Citation: Vl. Gates et al., HOW WELL DO WHOLE-BODY TRACER KINETICS PREDICT WHOLE-BODY THERAPY KINETICS IN I-131 ANTI-B1 LYMPHOMA RADIOIMMUNOTHERAPY, The Journal of nuclear medicine, 38(5), 1997, pp. 1063-1063
Authors:
ZASADNY KR
GATES VL
MOON S
REGAN DD
KAMINSKI MS
WAHL RL
Citation: Kr. Zasadny et al., DO TRACER DOSIMETRY STUDIES PREDICT NORMAL ORGAN AND TUMOR UPTAKE OF I-131 ANTI-B1 (ANTI CD-20) ANTIBODY IN PATIENTS RECEIVING RADIOIMMUNOTHERAPY FOR NON-HODGKINS-LYMPHOMA, Radiology, 205, 1997, pp. 509-509
Authors:
SUGAWARA Y
FISHER SJ
KISON PV
ZASADNY KR
WAHL RL
Citation: Y. Sugawara et al., CAN FDG-PET DETECT HUMAN INFECTIONS RAPIDLY, Radiology, 205, 1997, pp. 534-534
Authors:
TORIZUKA T
ARBOR A
ZASADNY KR
KISON PV
WAHL RL
Citation: T. Torizuka et al., KINETIC RATE CONSTANTS OF FDG PET IN PATIENTS WITH LUNG-CANCER, BREAST-CANCER, MALIGNANT-MELANOMA AND NON-HODGKIN-LYMPHOMA, Radiology, 205, 1997, pp. 1090-1090
Authors:
WAHL RL
FIG LM
ZASADNY KR
GROSS MD
WEICHERT JP
COUNSELL RE
Citation: Rl. Wahl et al., INITIAL CLINICAL-EVALUATION OF I-131 NM-324, A TUMOR-AVID PHOSPHOLIPID ETHER, IN HUMANS WITH CANCER, Radiology, 205, 1997, pp. 1429-1429
Authors:
KAMINSKI MS
ZASADNY KR
FRANCIS IR
FENNER MC
ROSS CW
MILIK AW
ESTES J
TUCK M
REGAN D
FISHER S
GLENN SD
WAHL RL
Citation: Ms. Kaminski et al., I-131 - ANTI-B1 RADIOIMMUNOTHERAPY FOR B-CELL LYMPHOMA, Journal of clinical oncology, 14(7), 1996, pp. 1974-1981